MOONLAKE IMMUNOTHERAPEUTICS Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 566.16 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2026-08-10
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2026-06-30 was 0.00 shares.
- MOONLAKE IMMUNOTHERAPEUTICS share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2026-03-31 was 566.16K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 6 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 566.16K shares 10-Q · filed 2026-08-10 |
| 2026-03-31 | 566.16K shares 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |